Product Overview
Dalbavancin | T21358 | TargetMol Chemicals
CAS: 171500-79-1
Smiles: Cl.[H][C@@]12Cc3ccc(Oc4cc5cc(Oc6ccc(cc6Cl)[C@@H](O)[C@]6([H])NC(=O)[C@]([H])(NC(=O)[C@]5([H])NC(=O)[C@@]([H])(NC1=O)c1cc(Oc5cc(ccc5O)[C@@H](NC)C(=O)N2)cc(O)c1Cl)c1ccc(O)c(c1)-c1c(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)cc(O)cc1[C@]([H])(NC6=O)C(=O)NCCCN(C)C)c4O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1NC(=O)CCCCCCCCC(C)C)C(O)=O)cc3
Formula: C88H101Cl3N10O28
Pathway: Microbiology/Virology
Target: Antibacterial|||Antibiotic
Receptor: N/A
Bioactivity: Dalbavancin, a novel second-generation lipoglycopeptide antibiotic, possesses in vitro activity against a variety of Gram-positive pathogens including methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE), Dalbavancin hydrochloride inhibits Staphylococcus aureus and Bacillus anthracis with MIC90s of 0.06 μg/mL and 0.25 μg/mL, respectively
Molecular Weight: 1853, 17